Charles River Laboratories International (CRL) Common Equity (2009 - 2026)
Charles River Laboratories International's Common Equity was $2.85 billion in Q2 2026, down 15.3% from $3.36 billion a year earlier and down 3.4% from the prior quarter.
Powered by 
Analysis
Charles River Laboratories International (CRL) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Charles River Laboratories International came in at $3.17 billion, down 8.6% from FY2024.
- Common Equity shows a five-year compound annual growth rate of 8.4% (FY2020 to FY2025).
- In earlier years, Common Equity was $3.47 billion in FY2024 (-3.8%), $3.6 billion in FY2023 (+20.8%), $2.98 billion in FY2022 (+17.4%) and $2.54 billion in FY2021 (+19.9%).
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q3 2022.
- Compared with a year earlier, Common Equity has declined for seven straight quarters, with an average decline of 6.6% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q3 2021 (growth of 27.9%); the worst was Q2 2026 (a decline of 15.3%).
- Per Business Quant data, CRL's Common Equity in the three quarters before Q2 2026 was $2.95 billion (Q1 2026), $3.17 billion (Q4 2025) and $3.41 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 43.55 Bn | 35.25 Bn | 1.44 Bn | 6.30 Bn |
| 2 | Medpace Holdings | 17.35 Bn | 15.42 Bn | 201.64 Mn | 433.86 Mn |
| 3 | Charles River Laboratories International | 14.59 Bn | 13.78 Bn | 363.37 Mn | 2.85 Bn |
| 4 | Icon | 13.15 Bn | 10.27 Bn | 479.29 Mn | 9.38 Bn |
| 5 | Fortrea Holdings | 2.03 Bn | 1.40 Bn | 139.20 Mn | 524.20 Mn |
| 6 | Ginkgo Bioworks Holdings | 722.47 Mn | -39.62 Mn | 18.44 Mn | 420.28 Mn |
| 7 | Evotec SE | 504.11 Mn | -1.11 Bn | - | 760.23 Mn |
| 8 | Champions Oncology | 66.57 Mn | 41.65 Mn | 7.70 Mn | 4.46 Mn |
| 9 | MindWalk Holdings | 63.08 Mn | 26.73 Mn | 1.61 Mn | 4.93 Mn |
| 10 | Natural Alternatives International | 6.81 Mn | -21.27 Mn | 1.73 Mn | 49.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 2.85 Bn |
| Mar 28, 2026 | 2.95 Bn |
| Dec 27, 2025 | 3.17 Bn |
| Sep 27, 2025 | 3.41 Bn |
| Jun 28, 2025 | 3.36 Bn |
| Mar 29, 2025 | 3.20 Bn |
| Dec 28, 2024 | 3.47 Bn |
| Sep 28, 2024 | 3.79 Bn |
| Jun 29, 2024 | 3.73 Bn |
| Mar 30, 2024 | 3.65 Bn |
| Dec 30, 2023 | 3.60 Bn |
| Sep 30, 2023 | 3.31 Bn |
| Jul 1, 2023 | 3.26 Bn |
| Apr 1, 2023 | 3.11 Bn |
| Dec 31, 2022 | 2.98 Bn |
| Sep 24, 2022 | 2.63 Bn |
| Jun 25, 2022 | 2.65 Bn |
| Mar 26, 2022 | 2.61 Bn |
| Dec 25, 2021 | 2.54 Bn |
| Sep 25, 2021 | 2.43 Bn |
API Access
Charles River Laboratories International Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CRL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CRL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CRL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();